|
The manufacturer was informed of this event through patient tracking database.Based on the information received from the patient's implant form, on 14 february 2022, a carbomedics standard prosthetic mitral heart valve, m7-025 was implanted and explanted intra-operatively and another m7-025 was implanted in the patient instead.There is no allegation of device malfunction nor serious injury on the patient.
|
|
A complete manufacturing and material records review for the device has been performed.The results confirmed that the device satisfied all material, visual and performance standards required at the time of manufacture and release.The manufacturer attempted to retrieve additional information on this event, and the device involved.However, no further information has been provided to date, despite the manufacturer's attempts.Based on the limited information available, it is not possible to establish a definitive root cause for the reported event.However, from the document review performed, no manufacturing deficiencies were identified.Should any further information be received in the future, the manufacturer will re-visit the case and take further actions as applicable.Unknown disposition.
|